Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF - Get Free Report) announced a dividend on Wednesday, February 26th, NASDAQ Dividends reports. Investors of record on Friday, March 21st will be paid a dividend of 0.48 per share on Thursday, May 1st. The ex-dividend date of this dividend is Friday, March 21st. This is a positive change from Hikma Pharmaceuticals's previous dividend of $0.47.
Hikma Pharmaceuticals Price Performance
OTCMKTS:HKMPF remained flat at $27.17 during trading hours on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.66 and a quick ratio of 0.98. Hikma Pharmaceuticals has a twelve month low of $22.33 and a twelve month high of $28.92. The stock's 50 day moving average is $26.09 and its two-hundred day moving average is $25.36.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada upgraded shares of Hikma Pharmaceuticals from a "hold" rating to a "moderate buy" rating in a report on Tuesday, December 10th.
View Our Latest Stock Analysis on HKMPF
Hikma Pharmaceuticals Company Profile
(
Get Free Report)
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Articles
Before you consider Hikma Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hikma Pharmaceuticals wasn't on the list.
While Hikma Pharmaceuticals currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
